PL
ProPhase Labs Inc
🇺🇸XNAS.PRPHUnited StatesHealthcare
$0.36USDdown -0.09 (-20%)OpenDelayed2:23 PM
Price$0.36-0.09 (-20%)
Profile
- Healthcare
- Diagnostics & Research
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US74345W1080
- CUSIP
- 74838L304
Company
- Employees
- 19
- Headquarters
- Uniondale, United States
- Website
- https://www.prophaselabs.com
- CEO
- Mr. Ted William Karkus
Market
- Shares outstanding
- 15.6M
- Market cap
- $1.51M
Highlights
- Market cap
- $1.51M
- EPS LTM
- -$1.45calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -0.25calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $3.16M-5.51%down year on year
- Net income
- -$22.64M+45.38%up year on year
- Gross margin
- 16.38%-72.9%down year on year
- Free cash flow
- -$30.69M-174.72%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.